BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4466883)

  • 1. [Thrombohemorrhagic syndrome in systemic lupus erythematosus].
    Iakimova NIa; Sukhanov AA
    Klin Med (Mosk); 1974 Jan; 52(1):37-41. PubMed ID: 4466883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of the thrombohemorrhagic syndrome in patients with systemic lupus erythematosus].
    Angelutsa PA; Ivanova NV; Vasil'ev VV; Vas'kova NG; Kosiuk LN
    Vrach Delo; 1989 Jan; (1):50-2. PubMed ID: 2718447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the thrombocyte and erythrocyte components of hemostasis in the development of thrombohemorrhagic complications in patients with systemic lupus erythematosus].
    Gritsiuk AI; Ivanova NV; Vas'kova NG; Kosiuk LN; Poltavets NI
    Vrach Delo; 1990 Dec; (12):21-3. PubMed ID: 2089792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemorrhage and thrombosis in systemic lupus erythematosus patients].
    Jin A
    Zhonghua Nei Ke Za Zhi; 1983 Nov; 22(11):707-9. PubMed ID: 6675935
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circulating anticoagulants in systemic lupus. Apropos of 60 patients. Multicenter study conducted by the research department of the SNFMI].
    Le Thi Huong Du; Guillevin L; Arlet Suau E; Bercoff E; Pasquali JL; Beylot J; Kaloustian E; Garabedian C; Agius D; Beaugrand M
    Ann Med Interne (Paris); 1987; 138(4):246-50. PubMed ID: 3115165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical manifestations and the pathogenetic aspects of the hemorrhagic syndrome in systemic lupus erythematosus].
    Ivanova AV; Iakimova NIa; Tinigin PA
    Ter Arkh; 1982; 54(6):57-60. PubMed ID: 7112421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombohemorrhagic syndrome in various liver diseases].
    Kuznik BI; Pateiuk VG; Komarov NA; Korotkova AP; Makovskaia TP
    Ter Arkh; 1978; 50(7):101-7. PubMed ID: 715706
    [No Abstract]   [Full Text] [Related]  

  • 8. Review: antiphospholipid antibodies and the lung.
    Asherson RA; Cervera R
    J Rheumatol; 1995 Jan; 22(1):62-6. PubMed ID: 7699684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coagulation and acute disseminated lupus erythematosus. Apropos of 25 cases].
    Godeau P; Herreman G; Raby C; Levassor M
    Sem Hop; 1977 Mar; 53(10):609-12. PubMed ID: 194314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome].
    Engelsen J; Nielsen SM; Thorsen S
    Ugeskr Laeger; 2006 Jan; 168(5):486-7. PubMed ID: 16472441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budd-Chiari syndrome with inferior vena cava obstruction associated with systemic lupus erythematosus.
    Disney TF; Sullivan SN; Haddad RG; Lowe D; Goldbach MM
    J Clin Gastroenterol; 1984 Jun; 6(3):253-6. PubMed ID: 6725916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorrhagic manifestations in systemic lupus erythematodes. Analysis of findings in 11 patients and review of the literature].
    Vachtenheim J
    Z Arztl Fortbild (Jena); 1965 Jul; 59(14):772-9. PubMed ID: 5887152
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral arterial thrombosis in systemic lupus erythematosis and nephrotic syndrome: possible association with protein S deficiency.
    Beşbaş N; Doğru D; Bakkaloğlu A; Ozen S; Balkanci F; Saatçi U
    Turk J Pediatr; 1997; 39(1):143-7. PubMed ID: 10868207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating anticoagulants in systemic lupus erythematosus].
    Durán-Suárez JR
    Med Clin (Barc); 1983 Jul; 81(5):203-6. PubMed ID: 6621162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic disease and thrombosis of the major vessels].
    Wechsler B; Fassin D; Godeau P
    J Mal Vasc; 1984; 9(4):315-7. PubMed ID: 6527074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome].
    Alekberova ZS; Reshetniak TM; Rodenska-Lopovok SG; Aleksandrova EN; Kalashnikova LA; Nasonov EL; Mach ES; Nasonova VA
    Ter Arkh; 1995; 67(5):41-4. PubMed ID: 7638777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coagulation disorder in lupus erythematosus caused by consumption].
    Papilian M; Ciobanu V; Stroescu O
    Med Interna (Bucur); 1967 Jul; 19(7):827-34. PubMed ID: 6052169
    [No Abstract]   [Full Text] [Related]  

  • 20. [The lupus inhibitor].
    Carreras LO; Vermylen J
    Sangre (Barc); 1981; 26(5-A):610-8. PubMed ID: 6798699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.